Relevance of Talos programme reanalysis yield to "Reanalyse unresolved rare-disease cases"
- Use case
- Reanalyse unresolved rare-disease cases
- Assessed by
- Talos programme reanalysis yield
- Relevance
- Direct evidence
- Endpoint
- New confirmed diagnoses and review workload during monthly reanalysis
Direct programme-level reanalysis outcomes in a previously unresolved cohort; does not isolate method benefit.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
15 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations1 values
| Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint New confirmed diagnoses and review workload during monthly reanalysis Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:uc-clinical-20260930-reanalysis-programme-protocol Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations2 values
| Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Pinned records18 values
| Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Rationale Direct programme-level reanalysis outcomes in a previously unresolved cohort; does not isolate method benefit. Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Reason Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations. Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Relevance direct Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Revision 1 Context-only references | Automated reanalysis of genomic data for rare disease diagnostics at scale uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods Version: Nature Medicine 2026 final publication, 24 June 2026 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Automated reanalysis of genomic data for rare disease diagnostics at scale · Original source · Nature Medicine 2026 final publication, 24 June 2026
Technical metadata and extraction receipts
Stable ID: use-case-mapping-20260930-342-3c7f6c5e1873
- field
- links:assessed_by:uc-clinical-20260930-reanalysis-programme-protocol
- value
- uc-clinical-20260930-reanalysis-programme-protocol
- relevance
- direct
- endpoint
- New confirmed diagnoses and review workload during monthly reanalysis
- rationale
- Direct programme-level reanalysis outcomes in a previously unresolved cohort; does not isolate method benefit.
- constraints
- 4735 individuals; diagnoses and individuals distinct; staggered repeated cycles.; Original analysis 2017–2022; monthly programme 2023–2025.
- limitations
- No equal-input refreshed conventional control.; No randomization/blinding; updated calls and knowledge contribute to yield.
- revision
- 1
- reason
- Add independently checked primary-source protocol evidence from the 17-use-case coverage audit; retain narrower endpoint and transfer limitations.
- citation locators
- source id: uc-clinical-20260930-source-talos; locator: Results, Iterative reanalysis; Methods
- source locator
- uc-clinical-20260930-source-talos: Results, Iterative reanalysis; Methods
- review
- method: automated-source-review; reviewer: codex; reviewer note: Codex source curation, independent worker cross-review and root integration review; reviewed at: 2026-09-30T21:54:30.217Z; note: Source-backed literature curation with independent automated transcription and scope checks. No new model execution, independent experimental replication, qualified human scientific review or clinical validation.
- reviewed evaluations
- uc-clinical-20260930-reanalysis-programme-evaluation
- pins
- record id: uc-clinical-20260930-reanalysis-additional-diagnostic-yield; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 6f37059352aff99e97eb1df247c7c8b1883488dc7817a7901c8f118ea7e98a0b; record id: uc-clinical-20260930-reanalysis-first-cycle-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 525913c3bcc81cef99750055e20393ac43e9446c9c2efd2b6d165658b8ce17a5; record id: uc-clinical-20260930-reanalysis-first-cycle-share; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ef605a61ee68a32c1dd5eda7a14cfb8959e9767fb0b9c7d142d7733133dd15ea; record id: uc-clinical-20260930-reanalysis-improved-analysis-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 71721b2e0bb76167521dc9ccabf55a2b699b9f08afca4dd324ec95d79cdaf689; record id: uc-clinical-20260930-reanalysis-improved-analysis-share; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: a69f5d247686bc1e088ecb4b8f496cacf22ae946c3382159a206fbe4069d37c9; record id: uc-clinical-20260930-reanalysis-later-cycle-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 256368f9e767ca8f8df4fd4b6a81ccf2e622ff20b63da76dd5bb3c548b92ae0a; record id: uc-clinical-20260930-reanalysis-later-cycle-share; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: a6eb3d403eb822a9f2b98ac1617ef5e1a81a0a862fd842ec30799d2ee138dcf8; record id: uc-clinical-20260930-reanalysis-new-candidates-per-1000; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: e6001d3a4419f886e7686c2816f9cb697a9730d0864de0f33ebbb1536a976b5b; record id: uc-clinical-20260930-reanalysis-new-confirmed-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: fda2f9c934f657222db2fa6459499c200d771a44556d51e4c22ff820d12f2b3d; record id: uc-clinical-20260930-reanalysis-new-gene-disease-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 5c547776a65958fb090eea5507a77f0ac59ea30196699bdc2da52d0127bf8886; record id: uc-clinical-20260930-reanalysis-new-gene-disease-share; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 0bdf92b2357368c8b35040c056ec9c2cd81b1ba2d5b84d503680ab252850af34; record id: uc-clinical-20260930-reanalysis-new-variant-evidence-diagnoses; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 8408eba33641e92a35245b11f2ec3063079e5f502bf3caca4788b6a34f94fe3b; record id: uc-clinical-20260930-reanalysis-new-variant-evidence-share; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: e74009b2c80c08ea344167601aec769bff43d9d067912ab6d073cad9c38bad9d; record id: uc-clinical-20260930-reanalysis-newly-diagnosed-individuals; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 55f437ac504accff319a8df7d3a0730cc472c856dcc1c2a392eb86c2a7ad4045; record id: uc-clinical-20260930-reanalysis-programme-evaluation; fields: status; links; attributes.origin; attributes.comparison; sha256: 2e4576b281f148b2309926efbdfa473c9ae9f1844b88b0c3c5d5632674e2f973; record id: uc-clinical-20260930-reanalysis-programme-protocol; fields: status; name; description; facets; source_ids; links; attributes; sha256: 2bd52c48d6ad03e4346aaf5a9d25ec95b30bfd323613506980424fc1d46bcc9c; record id: uc-clinical-20260930-source-talos; fields: status; attributes.artifact_sha256; sha256: 90df8425bea523bb170910a4e057d9c3d0132ce74c82212e202b6114f188b4f3; record id: use-case-unresolved-rare-disease-reanalysis; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 7a34a11b2cbb377f490c4a4a0cb9bedc53fdc88b132b4c695cdd7b612f97476e